Professor at the College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Canada. Former Member of the Canadian Drug Expert Committee and the Manitoba Drug Standards and Therapeutics Committee. Member of the PEBC Panel of Examiners for the Pharmacist Evaluating Examination. Board member of the Women's Health Research Foundation of Canada.
Dr. Abdulaziz Alzarea holds doctorate in Pharmaceutical Economics and Policy (Health Economics and Outcomes Research) and is currently serving as head of the Department of Clinical Pharmacy in Jouf University, Saudi Arabia. He has broad experience in Publishing related to Clinical Pharmacy, Pharmacy Practice, Pharmacoeconomics, Pharmacoepidemiology and outcomes research.
Dr. Usman Ali Ashfaq, Professor of Molecular Biology and Group Leader, Health Biotechnology Group at the Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Pakistan. Dr. Usman Ali Ashfaq's expertise covers a range of subjects including, Molecular Biology, Virology, Molecular medicine, infectious diseases, integrated bioinformatics, Biotechnology and Genomics; more specifically his research covers the areas of diagnosis and treatment of infectious and metabolic diseases .
Dr. Mukund Chorghade is President and Chief Scientific Officer, THINQ Pharma / MVRC Research/ Chicago Discovery Solutions. He has had Adjunct Research Professor / Visiting Fellow / Scientists appointments at Harvard, MIT, Princeton, Cambridge, Caltech, Univ. of Chicago, Rutgers, Strathclyde and others. He provides synthetic chemistry and pharmaceutical development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. His research interests are in Traditional Medicine derived New Chemical Entities and the discovery of “chemosynthetic livers” that find utility in drug metabolism, valorization of biomass and environmental remediation.
Dr. Chorghade earned B. Sc. M. Sc. degrees from the University of Poona, and a Ph. D. at Georgetown University. He completed postdoctoral appointments at the University of Virginia and Harvard, visiting scientist appointments at University of British Columbia, College de France / Universite’ Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. He received three “Scientist of the Year Awards”, and is on the Scientific Advisory Board of several corporations / foundations. He is a Fellow of the ACS, AAAS, AIC and RSC, the Maharashtra, Andhra Pradesh and Telengana Academy of Sciences and has been a featured speaker in national and international symposia
Affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland (Bacteriophage Laboratory).Position: professor.
Current field of interest: non-bactericidal effects of phages in mammals; i.e. phage molecular biology tools for studies of phage impact on immunological system and other physiological aspects in mammals.
Mainly involved in the discovery of new bioactive compounds from Antarctic and Arctic bacteria. Also working on on Antarctic psychrophilic microorganisms with potential biotechnological applications, and the dissection of the virulence determinants of some human pathogens by the use of non-vertebrate host model, like Caenorhabtidis elegans.
Dr. Liang Gao currently works as a senior Research Fellow at the Center of Experimental Orthopaedics, Saarland University, Germany. His clinical interests include sports medicine, arthroplasty, and traumatology. His research focuses on joint preservation and orthobiologics.
Dr. Gao studied Medicine in China and Germany with intensive fellowship training in both Asia and Europe. He completed the orthopaedic residency training at Peking University Medical Center, China and received the ECFMG certificate. Moreover, he obtained his master of science degree from Heidelberg University, Germany and his doctorate summa cum laude from Saarland University, Germany.
Dr. Gao is the Member of the Basic Science Committee of International Cartilage Regeneration & Joint Preservation Society (ICRS), the Member of the Young Investigator Committee of Osteoarthritis Research Society International (OARSI), and the Founding Member of the Sino Euro Orthopaedics Society (SEOS). He also serves in other international societies including ESSKA, AOSSM, ICMRS, and ORS.
Professor of Vascular Pharmacology, University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath and Professor of Cardiovascular Pharmacology, University of Bristol. Visiting Professorships; University of Nagoya, Japan, Monash University, Australia and the National Academy of Sciences, Taiwan.
Jeremiah's research focuses on several areas:
Development of stimuli responsive "smart" biomaterials
Creating new thermosalient molecular crystalline materials
Using metal-organic frameworks for native protein (i.e. drug) delivery
Supramolecular and macromolecular organic radical contrast agents as MRI sensors
Associate Professor, Thoracic/Head and Neck Medical Oncology, Moores Cancer Center, University of California San Diego
Professor, Joint Department of Biomedical Engineering at UNC-CH and NCSU and Department of Pharmacology at UNC-CH. Previous Florence Gould Scholar and Pasteur Foundation Fellow. Current research interests in systems and synthetic biology, bioimage informatics, and network science applied to biology. Broader interests in translational medicine and the fostering of innovative solutions to problems in healthcare.
Dr. Hidekazu Hiroaki is Professor within the Graduate School of Pharmaceutical Sciences, Nagoya University, Japan. He received his PhD in Pharmaceutical Sciences (PhD thesis "Spectroscopic study for interaction between DNA oligonucleotide and bleomycin”) from the Graduate School of Osaka University, Japan in 1992.
Dr Hiroaki's research focuses on the structural biology of proteins by using solution NMR techniques, including protein-protein and protein-drug interaction. He is also focusing on NMR-assisted in silico drug discovery as well as protein structure determination. He is also an expert of intrinsically disordered proteins and some disease related amyloid genic proteins.
2012-present: Professor, Graduate School of Pharmaceutical Sciences, Nagoya University (Nagoya, Aichi, Japan)
2011-2012: Professor, Research Center for Structural Biology, Department of Science, Nagoya University (Nagoya, Aichi, Japan)
2007-2011: Professor, Division of Structural Biology, Graduate School of Medicine, Kobe University, (Kobe, Hyogo, Japan)
2001-2007: Associate Professor, International Graduate School of Art and Science, Yokohama City University, (Kanagawa, Japan)
1995-2001: Research Scientist, Division of Structural Biology, Biomolecular Engineering Research Institute (BERI) (Suita, Osaka, Japan)
1994-1995: Visiting Scientist, Research Centre, F Hoffman La Roche (Basel, Switzerland)
1992-1994: Research Scientist, Department of Molecular Genetics, Nippon Roche Research Center (Kanagawa, Japan)